BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16848014)

  • 1. Homocysteine, B vitamins, and cardiovascular disease.
    Refsum H; Smith AD
    N Engl J Med; 2006 Jul; 355(2):207; author reply 209-11. PubMed ID: 16848014
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine, B vitamins, and cardiovascular disease.
    Wang X; Demirtas H; Xu X
    N Engl J Med; 2006 Jul; 355(2):207-9; author reply 209-11. PubMed ID: 16838445
    [No Abstract]   [Full Text] [Related]  

  • 3. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 4. Homocysteine, B vitamins, and cardiovascular disease.
    Khare A; Lopez M; Gogtay J
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16848015
    [No Abstract]   [Full Text] [Related]  

  • 5. Homocysteine, B vitamins, and cardiovascular disease.
    Tomlinson DR; Lang D; Lewis MJ
    N Engl J Med; 2006 Jul; 355(2):209; author reply 209-11. PubMed ID: 16838444
    [No Abstract]   [Full Text] [Related]  

  • 6. Homocysteine, B vitamins, and cardiovascular disease.
    de Craen AJ; Stott DJ; Westendorp RG
    N Engl J Med; 2006 Jul; 355(2):205-6; author reply 209-11. PubMed ID: 16837687
    [No Abstract]   [Full Text] [Related]  

  • 7. Homocysteine trials--clear outcomes for complex reasons.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(15):1629-32. PubMed ID: 16531615
    [No Abstract]   [Full Text] [Related]  

  • 8. The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?
    Abraham JM; Cho L
    Cleve Clin J Med; 2010 Dec; 77(12):911-8. PubMed ID: 21147945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nutritional medicine 2007].
    Hauner H
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1411-3. PubMed ID: 17570092
    [No Abstract]   [Full Text] [Related]  

  • 10. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine lowering and cognitive performance.
    Dettling M; Opgen-Rhein C; Anghelescu IG
    N Engl J Med; 2006 Sep; 355(13):1390; author reply 1391. PubMed ID: 17014040
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamins and minerals 4: overview of folate and the B vitamins.
    Thompson J
    Community Pract; 2006 Jun; 79(6):197-8. PubMed ID: 16780289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?
    Lonn E
    JAMA; 2008 May; 299(17):2086-7. PubMed ID: 18460669
    [No Abstract]   [Full Text] [Related]  

  • 15. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
    Strasser RH
    Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.
    Ebbing M; Bønaa KH; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Nilsen DW; Refsum H; Tverdal A; Vollset SE; Schirmer H; Bleie Ø; Steigen T; Midttun Ø; Fredriksen A; Pedersen ER; Nygård O
    J Intern Med; 2010 Oct; 268(4):367-82. PubMed ID: 20698927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
    Birn H
    Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention: B vitamins and CVD--failure to find a simple solution.
    Ebbing M; Ueland PM
    Nat Rev Cardiol; 2010 Nov; 7(11):608-9. PubMed ID: 20975658
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
    Siragusa S; Malato A; Cigna V; Anastasio R; Coco LL; Casuccio A; Ciaccio M
    Thromb Res; 2007; 121(1):51-3. PubMed ID: 17462714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.